ANDREA CARPENTER: Open Payments
NPI 1780169557 · MANTACHIE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 21 payments from 8 companies in 2025. Trend: 2023 $508 · 2024 $506 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| Corcept Therapeutics | 4 | $78 |
| Sequel Med Tech, LLC | 3 | $66 |
| Lilly USA, LLC | 3 | $46 |
| CeQur Corporation | 1 | $21 |
| Amgen Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: FARXIGA, Korlym, TWIIST, MOUNJARO, JARDIANCE, CeQur Simplicity, EVENITY, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
